Learn more Webcast featuring eSpOT-ON
Explore More eSpOT-ON Nuclease Protein Available Now
Explore More Order eSpOT-ON Nuclease mRNA Now

AstraZeneca, Synthego ink gene editing enzyme licensing deal

January 13

About Synthego

Synthego is a pioneering biotechnology company specializing in synthetic biology and genome engineering. Dedicated to providing scientists with the tools, expertise, and support needed to accelerate scientific discovery, Synthego’s expansion into molecular and clinical diagnostic reagents reaffirms its commitment to innovation and leadership in the life sciences industry.

Media Contact

Synthego Media Relations

Email: [email protected]

Website: www.synthego.com